Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies

Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies

Показать другие версии (1)

OBJECTIVE:Fatigue is a common and disabling symptom amongst people with multiple sclerosis, however it has not been compared across the central nervous system (CNS) inflammatory diseases associated with aquaporin-4 (AQP4) and myelin oligodendrocyte glycoprotein (MOG) antibodies (Ab). We explored the...

Полное описание

Библиографические подробности
Главные авторы:	Yeo, T, Dos Passos, GR, Muhammed, L, Everett, R, Reeve, S, Messina, S, Probert, F, Leite, MI, Jacqueline Palace
Формат:	Journal article
Язык:	English
Опубликовано:	Wiley 2020

Схожие документы

Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies
по: Tianrong Yeo, и др.
Опубликовано: (2020-03-01)

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease.
по: Jurynczyk, M, и др.
Опубликовано: (2017)

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease
по: Jurynczyk, M, и др.
Опубликовано: (2017)

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease
по: Maciej Jurynczyk, и др.
Опубликовано: (2017-12-01)

Distinguishing the brain MRI features of MS, AQP4-and MOG-antibody disease.
по: Jurynczyk, M, и др.
Опубликовано: (2016)

Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS
по: Waters, P, и др.
Опубликовано: (2015)

RELAPSING AQP4 ANTIBODY NEGATIVE NMO WITH MOG ANTIBODIES
по: Elsone, L, и др.
Опубликовано: (2014)

Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease
по: Juryńczyk, M, и др.
Опубликовано: (2016)

The influence of smoking on the pattern of disability and relapse risk in AQP4-positive Neuromyelitis Optica Spectrum Disorder, MOG-Ab Disease and Multiple Sclerosis
по: Messina, S, и др.
Опубликовано: (2021)

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
по: Sato, D, и др.
Опубликовано: (2014)

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
по: Kezuka, T, и др.
Опубликовано: (2014)

No strong HLA association with MOG antibody disease in the UK population
по: Grant-Peters, M, и др.
Опубликовано: (2021)

Value of Area Postrema Syndrome in Differentiating Adults With AQP4 vs. MOG Antibodies
по: Jae-Won Hyun, и др.
Опубликовано: (2020-06-01)

International multicenter examination of MOG antibody assays
по: Reindl, M, и др.
Опубликовано: (2020)

Time to separate MOG-Ab-associated disease from AQP4-Ab-positive neuromyelitis optica spectrum disorder
по: Hacohen, Y, и др.
Опубликовано: (2018)

No strong HLA association with MOG antibody disease in the UK population
по: Melissa Grant‐Peters, и др.
Опубликовано: (2021-07-01)

Features of the diagnosis and treatment of patients with AQP-4-positive neuromyelitis optica and MOG antibody disease
по: V. E. Avdeeva, и др.
Опубликовано: (2021-11-01)

Disease course and disability outcomes in MOG-antibody disease in the UK
по: Jurynczyk, M, и др.
Опубликовано: (2017)

Prevalence of serum MOG antibody and AQP4 antibody in optic neuritis after SARS-CoV-2 infection
по: Chuan-bin Sun
Опубликовано: (2023-11-01)

Clinical presentation and prognosis in MOG-antibody disease: a UK study
по: Jurynczyk, M, и др.
Опубликовано: (2017)

A Longitudinal Comparison of the Recovery Patterns of Optic Neuritis with MOG Antibody-Seropositive and AQP4 Antibody-Seropositive or -Seronegative for Both Antibodies
по: Lin Zhou, и др.
Опубликовано: (2022-01-01)

Differences in Neuropathic Pain and Radiological Features Between AQP4-ON, MOG-ON, and IDON
по: Hao Kang, и др.
Опубликовано: (2022-05-01)

Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodies
по: Elisabeth Maillart, и др.
Опубликовано: (2020-04-01)

Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric Method
по: Luca Bollo, и др.
Опубликовано: (2021-03-01)

Case report: Satralizumab as an adjunctive therapy for AQP-4 antibody and MOG antibody dual-negative optic neuritis in a third-trimester pregnancy case
по: Chuanbin Sun, и др.
Опубликовано: (2024-12-01)

Different immunological mechanisms between AQP4 antibody-positive and MOG antibody-positive optic neuritis based on RNA sequencing analysis of whole blood
по: Xuelian Chen, и др.
Опубликовано: (2023-03-01)

Corrigendum: Different immunological mechanisms between AQP4 antibody-positive and MOG antibody-positive optic neuritis based on RNA sequencing analysis of whole blood
по: Xuelian Chen, и др.
Опубликовано: (2023-08-01)

Case Report: Anti-NMDAR Encephalitis With Anti-MOG CNS Demyelination After Recurrent CNS Demyelination
по: Bing-Yan Ren, и др.
Опубликовано: (2021-02-01)

Efficacy for the Annual Relapse Rate after the Immunosuppressive Therapy in Patients Associated with Anti-AQP4 or Anti-MOG Antibody-Positive Optic Neuritis
по: Sotaro Mori, и др.
Опубликовано: (2020-01-01)

Structural and Functional Alterations in Visual Pathway After Optic Neuritis in MOG Antibody Disease: A Comparative Study With AQP4 Seropositive NMOSD
по: Chenyang Gao, и др.
Опубликовано: (2021-06-01)

We need to talk about MOG
по: Waters, P, и др.
Опубликовано: (2020)

Frequency of MOG-IgG in cerebrospinal fluid versus serum
по: Pace, S, и др.
Опубликовано: (2021)

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
по: Jarius, S, и др.
Опубликовано: (2018)

Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients
по: Whittam, DH, и др.
Опубликовано: (2020)

MOG antibody associated disorder (MOGAD)
по: Lilley Kate, и др.
Опубликовано: (2021-01-01)

Epilepsy in patients with MOG antibody disease
по: Varvara E. Avdeeva, и др.
Опубликовано: (2021-10-01)

Usefulness of optical coherence tomography to distinguish optic neuritis associated with AQP4 or MOG in neuromyelitis optica spectrum disorders
по: Elena H. Martinez-Lapiscina, и др.
Опубликовано: (2016-09-01)

A rare case of systemic lupus erythematosus‐associated neuromyelitis optica spectrum disorder with cystic lesions and dual seropositivity for anti‐AQP4 and anti‐MOG antibodies
по: Omar Al Jassem, и др.
Опубликовано: (2024-09-01)

The Role of Peripheral CNS‐Directed Antibodies in Promoting Inflammatory CNS Demyelination
по: Silke Kinzel, и др.
Опубликовано: (2017-06-01)

Atypical inflammatory demyelinating syndromes of the CNS
по: Hardy, T, и др.
Опубликовано: (2016)